Alpha-synuclein propagation: New insights from animal models
Benjamin Dehay1,2, Miquel Vila3,4,5, Erwan Bezard1,2
1Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.
Movement Disorders : Official Journal of the Movement Disorder Society
|September 9, 2015
Summary
Misfolded alpha-synuclein spreads between cells, driving neurodegenerative synucleinopathies. Animal models reveal this cell-to-cell transmission, informing human disease understanding and therapeutic strategies targeting alpha-synuclein propagation.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Synucleinopathies are neurodegenerative diseases linked to alpha-synuclein aggregation.
- Cell-to-cell transmission of misfolded alpha-synuclein is a key pathogenic mechanism.
- Animal models are crucial for studying alpha-synuclein pathology and its effects.
Purpose of the Study:
- To review evidence from animal models supporting cell-to-cell spread of alpha-synuclein.
- To correlate findings in animal models with human synucleinopathies.
- To discuss mechanisms and therapeutic strategies for alpha-synuclein propagation.
Main Methods:
- Review of existing research and animal model studies.
- Analysis of molecular and cellular mechanisms of alpha-synuclein spread.
- Exploration of therapeutic interventions targeting alpha-synuclein.
Main Results:
- Animal models demonstrate the cell-to-cell propagation of misfolded alpha-synuclein.
- This spread contributes to neuronal dysfunction and behavioral deficits.
- Findings in models offer insights into human disease progression.
Conclusions:
- Cell-to-cell transmission of alpha-synuclein is a validated mechanism in synucleinopathies.
- Animal models are instrumental in understanding this process.
- Targeting alpha-synuclein propagation presents promising therapeutic avenues.
